Shijia Bian retweeted
This has been a huge team effort together with Shijia Bian, @EricDammer, Juan Fortea and Erik C.B. Johnson!! Thanks to all the other co-authors @NicholasAshton , @SantPauMemory, @EmoryUniversity for your contribution!!
Shijia Bian retweeted
🚨 In this paper in @NatureCommuniations, we find that Down syndrome #Alzheimer exhibits unique pathological features compared with sporadic late-onset and autosomal dominant AD with important implications for treatment strategies.
nature.com/articles/s41467-0…
Shijia Bian retweeted
Excited to share our paper, Health risks and genetic architecture of objectively measured multidimensional sleep health, led by Shengkui Zhang, Manrui Zhang, and Yuxin Yuan, is now online in Nature Communications🎉 Many thanks to co-authors, Xiaoyu Li and @muzizimumu1, and to all UK Biobank and MESA participants for making this work possible.
Sleep is a fundamental physiological process with multiple dimensions. Yet, most existing studies have focused on individual dimension, such as sleep duration or insomnia, often relying on self-reported data and small sample sizes. These limitations have hindered a comprehensive understanding of the associations between real-world sleep patterns and health 🛏️
We developed a multidimensional sleep health index using wrist-worn accelerometer data from 85,233 UK Biobank participants, and systematically investigated its health consequences, environmental determinants, and genetic basis.
We constructed the Unfavorable Sleep Profile (USP) that captures five objectively measured sleep dimensions: timing, duration, efficiency, regularity, and rhythmicity. USP was observed in 18.9% of the population and characterized by delayed timing, short sleep, low efficiency, irregular sleep, and weak circadian rhythms.
Using linked health records, we performed a phenome-wide association study (PheWAS) covering 526 disease endpoints over 7.9 years of follow-up. USP was associated with increased risks of all-cause and cardiovascular mortality, and with 76 diseases across mental, metabolic, cardiovascular, respiratory, infectious, and injury-related domains.
To estimate the public health relevance of USP, we calculated the population attributable fraction (PAF) for USP-associated outcomes. USP was estimated to account for 5.7% of all-cause mortality, 9.25% of cardiovascular mortality, and 2.3% to 12.3% of incident cases across 76 diseases.
Several modifiable social and behavioral risk factors were linked to USP, including lower education, social deprivation, lack of partner support, obesity, smoking, and heavy alcohol consumption, suggesting potential intervention targets.
At the genetic level, utilizing both WES and WGS data from the UK Biobank, USP was associated with common variants in MEIS1 (previously linked to restless legs syndrome), rare coding variants in TTC1, and enhancer variants near CDK8. Functional evidence suggests TTC1 may influence sleep through interactions with the circadian protein CRY2.
Mendelian randomization supported potential causal effects of USP on several conditions, such as iron deficiency anemias, anxiety disorder, iron deficiency anemias, and migraine. A polygenic score for USP showed significant associations with 32 disease traits after Bonferroni correction.
Finally, we validated the USP index in the Multi-Ethnic Study of Atherosclerosis (MESA) cohort, demonstrating its generalizability across ancestries and measurement platforms. By objectively defining and validating a multidimensional sleep health index at scale, our study underscores the potential of wearable-derived sleep metrics to inform disease risk prediction, prevention strategies, and precision public health.
Link to paper: doi.org/10.1038/s41467-025-6…
Shijia Bian retweeted
A wonderful collaboration with @drarwood @XihongLin @muzizimumu1 @GarethHawkes1 @mnweedon and others on this work, where we introduce a streamlined cloud-based solution enabling efficient management and analysis of biobank-scale WGS data with a case study from the @uk_biobank🧬☁️
Excited to see our paper on medRxiv "Streamlining Large-Scale Genomic Data Management: Insights from the UK Biobank Whole-Genome Sequencing Data". medrxiv.org/cgi/content/shor…
Toolkit here:
github.com/drarwood/vcf2agds…. Thanks to @xihaoli @XihongLin and others for a great collaboration.
Shijia Bian retweeted
Replying to @xihaoli @NatureMedicine
Thank you so much for sharing our work! It was an honor to contribute to this research, and I'm deeply grateful for the team's support.
Shijia Bian retweeted
A fascinating new study just published online today in @NatureMedicine reports an extraordinary case of an individual carrying the PSEN2 (p.Asn141Ile) mutation—a known driver of dominantly inherited Alzheimer’s disease (DIAD)—who remained cognitively healthy well into his mid-70s. This is nearly 18 years past the expected age of onset. The study combines longitudinal clinical assessments, neuroimaging, genetic analysis, and proteomics to uncover the mechanisms underlying his remarkable resistance to Alzheimer’s (nature.com/articles/s41591-0…) 🎉🧬🧠🔍
The PSEN2 p.Asn141Ile mutation causes excessive production of amyloid-beta, resulting in amyloid plaques—one of the hallmarks of Alzheimer’s disease. While this individual’s brain was filled with amyloid deposits, the expected cognitive decline and dementia never materialized. Tau pathology, another key feature of Alzheimer’s, was restricted to the occipital lobe, a brain region associated with visual processing but not typically involved in Alzheimer’s-related cognitive decline. This rare localized tau pattern may explain the individual’s cognitive preservation and highlights the potential of tau-targeted therapies.
Over the course of 10 years of follow-up, the individual’s Cognitive Dementia Rating (CDR) and Mini-Mental State Examination (MMSE) scores remained normal (CDR = 0; MMSE = 30) for the subsequent four (2014, 2016, 2018 and 2021) assessments performed over 10 years, including the most recent evaluation in 2021 at age 71.
Genetic analysis in this study utilized whole-genome sequencing (WGS) and whole-exome sequencing (WES) on family members, including the exceptional resilience mutation carrier, to identify rare and common coding variants associated with resilience to Alzheimer’s disease. Segregation analysis prioritized variants that were exclusive to the resilience carrier or specific subgroups within the family. Several unique variants were identified within the 17q21.31 MAPT-H1 haplotype region, along with potential protective variants in AD-associated genes such as TREM2 and MAPT.
Proteomic profiling in this study identified an abundance of heat shock proteins, suggesting a potential adaptive stress response. Remarkably, this individual had prolonged exposure to high temperatures while working as a mechanic on a naval ship, requiring frequent cooling with water to prevent overheating. The heat-shock response triggered by such extreme conditions may have contributed to his resistance to neurodegeneration. These results suggest that a combination of genetic factors, environmental exposures, and enriched biological pathways may contribute to the delayed onset of AD in this individual.
The imaging data tell a powerful story. PET scans showed elevated amyloid burden with a PiB cortical SUVR (Z-scored relative to non-carriers aged 50 years old and above) of ~3.6, far above the threshold for abnormal amyloid deposition. However, tau PET imaging revealed that tau pathology remained focal and asymmetric, concentrated in the occipital lobe, rather than spreading to key regions like the medial temporal lobe or parietal cortex, which are typically affected in Alzheimer’s disease. This restricted tau spread contrasts sharply with the usual progression seen in mutation carriers, where tau accumulation is tightly linked to cognitive decline.
MRI scans showed that hippocampal volume declined only modestly over the 10 years of follow-up, consistent with normal aging rather than Alzheimer’s atrophy. FDG PET scans showed localized hypometabolism in areas with focal tau deposition, yet metabolic activity remained normal in other key brain regions.
From a broader perspective, this study raises questions about the amyloid hypothesis—the long-standing theory that amyloid plaques are the primary driver of Alzheimer’s. The case suggests that limiting tau deposition and spread may be more critical in preventing cognitive decline, even in the presence of substantial amyloid burden. This finding could reshape the focus of Alzheimer’s research and clinical trials, emphasizing tau-targeted therapies.
The proteomic analysis further revealed significant differences in this individual’s plasma proteome and cerebrospinal fluid (CSF) compared to typical PSEN2 carriers. Notably, pathways related to protein folding, synaptic function, and oxidative stress were enriched, with multiple heat shock proteins showing elevated expression. These proteins may play a crucial role in maintaining cellular homeostasis and protecting against protein misfolding, a common feature of neurodegenerative diseases.
In summary, this study opens exciting new avenues for Alzheimer’s research by identifying potential protective genetic and proteomic factors. It underscores the importance of studying rare resilience cases to uncover new therapeutic strategies. Restricting tau spread may prove to be a transformative approach in delaying or preventing dementia. The insights gained from this individual offer hope for developing precision medicine strategies for Alzheimer’s disease.
Huge congratulations to the research team—Jorge J. Llibre-Guerra, M. Victoria Fernandez, Nelly Joseph-Mathurin, @shijbian, Kathleen Carter, @ccrugom, Erik C. B. Johnson, @RandallBateman3, and many others—along with the Dominantly Inherited Alzheimer Network (DIAN), the study participant and his family members, whose dedication continues to pave the way for life-changing discoveries.
[About this post: this post is based on a summary of Llibre-Guerra, J.J., Fernandez, M.V., Joseph-Mathurin, N. et al. Longitudinal analysis of a dominantly inherited Alzheimer disease mutation carrier protected from dementia. Nat Med (2025). doi.org/10.1038/s41591-025-0…]
Shijia Bian retweeted
Please consider ⭐️submitting an abstract⭐️ (the deadline is approaching, submission link: forms.gle/6gJp8prNR3ZFZ6g36) and participating in the 2024 Boston Pharmaceutical Statistics Symposium! There will be ⚡️Lightning Talks⚡️ and 🍾Student Poster Competition🍾 showcasing the abstract submissions, a great lineup of speakers, networking opportunities, and more!
More information about the event: community.amstat.org/bostonc…
Shijia Bian retweeted
Super excited to see my first first-author paper on AJHG, in which we created FactorGo as a scalable tool to learn shared genetic components across traits using thousands of GWAS summary stats. Words can't describe my gratitude towards co-mentorship by @nmancuso_ and @StevenGazi
📢New @AJHGNews
📰A scalable approach to characterize pleiotropy across thousands of human diseases and complex traits using GWAS summary statistics
🧑🤝🧑@nmancuso_ & colleagues
cell.com/ajhg/fulltext/S0002…
I will attend ASHG2023 @GeneticsSociety and present our work with @EpsteinStatGen "A Statistical Framework for Genome-wide Interaction Testing Harnessing Cross-Trait Correlations" at 10:45 am on Thursday, Nov 2. I'd be happy to chat more with you about our work.
Several of our folks looking forward to #ASHG23! We've compiled platform talks + posters. Lots of representation from @EpsteinStatGen @BingYaoLab @elizjleslie @pengjinATL labs docs.google.com/document/d/1…
Shijia Bian retweeted
Several of our folks looking forward to #ASHG23! We've compiled platform talks + posters. Lots of representation from @EpsteinStatGen @BingYaoLab @elizjleslie @pengjinATL labs docs.google.com/document/d/1…
Incredibly fortunate to work with Drs. Erik Johnson, @Rafi_Haque, Kathleen Carter, and our co-authors. My gratitude also extends to my Ph.D. advisor, @EpsteinStatGen. This work would not have been possible without the efforts and support of the DIAN and all study participants.
This Post is from an account that no longer exists. Learn more
7
278
Shijia Bian retweeted
I am very delighted to announce that today is my first day to start an exciting position as Assistant Professor in the Department of Biostatistics (@uncbiostat) and the Department of Genetics at the University of North Carolina at Chapel Hill!
I wish to express my sincere gratitude to my mentors and collaborators, especially @XihongLin (my advisor), @IulianaLaza, @ginapeloso, @pnatarajanmd, Zilin Li, Bing Yu among many others), my new UNC colleagues, and my family @shijbian for their unwavering support throughout this journey. Their encouragement and guidance have played a significant role in shaping my career.
As I embark on this new chapter, I am filled with enthusiasm and anticipation for the remarkable opportunities that lie ahead at UNC. I am truly grateful for this opportunity and eager to contribute to the fields of biostatistics, genetics and -omics, bioinformatics, and the academic community (1/2).
Shijia Bian retweeted
Our MetaSTAAR paper just appeared in @NatureGenet today. MetaSTAAR provides a powerful, scalable and resource-efficient framework for rare variant association meta-analysis of large biobank-size whole-genome sequencing studies using summary statistics. (1/)nature.com/articles/s41588-0…
Shijia Bian retweeted
Our MACIE paper is online @AJHG today! Many thanks to @godwinyyung (co-lead), my amazing mentors @XihongLin, @IulianaLaza, and wonderful collaborators @zhouhufeng, @sunryan, Zilin Li, @kangchenghou @martinjzhang, Yaowu Liu, Ted Arapoglou, Chen Wang for making this paper possible
New! @XihongLin & colleagues present MACIE, a framework to improve prediction of variant function. Precomputed scores for all possible variants in the human genome are available for download!
https://teapaw.org/t.co/LCZnH7cpRZ
Shijia Bian retweeted
Cohort study finds, unlike hazard ratios and risk differences, restricted mean survival time (RMST) quantified a benefit of donepezil continuation in terms of an associated gain or loss in nursing home-free days. @HarvardChanSPH ja.ma/3cis8v9
TX Lockbox and Trump Administration are Ruining High-Skilled Foreign Stu... youtu.be/MZl3sTOIW1E via @YouTube
#f1optlockboxdelay #immigrants #immigrantrights #internationalstudents #highskilledworkers #intlstudents
1
Dynamic incorporation of multiple in silico functional... - recommended in @FacultyOpinions facultyopinions.com/prime/73…
Shijia Bian retweeted
My sincere gratitude to @XihongLin (my advisor), Dr. Zilin Li, @zhouhufeng, @sheilamgaynor, @pnatarajanmd, Dr. Gina Peloso, @cristenw, Dr. Jerome Rotter, all collaborators from @nih_nhlbi TOPMed Program and Lipids WG, and the support from my family for making this paper possible
Our STAAR paper just appeared in @NatureGenet. STAAR performs scalable, powerful rare variant associations tests for Whole Genome Sequencing studies by using multiple in-silico functional annotations, applied to lipids in @nih_nhlbi TOPMed 30K genomes (1/)
nature.com/articles/s41588-0…
Shijia Bian retweeted
Atlanta vaccine enrollment: @EmoryUniversity in Atlanta will begin enrolling healthy adult volunteers ages 18 to 55 years in a Phase 1 clinical trial of an investigational vaccine designed to prevent coronavirus disease 2019 (#COVID19) niaid.nih.gov/news-events/at…























